Mechanisms of digoxin-amiodarone interaction in the rat.
Amiodarone and digoxin are often used in combination and clinical experience suggests that amiodarone may increase serum digoxin levels and toxicity. We have investigated the influence of amiodarone on digoxin pharmacokinetics and tissue distribution in the rat. Forty-nine rats were injected with 10 mg/kg amiodarone sc three times a day for 7 days, while 49 others were injected with saline only. On the eighth day, all the rats received 0.5 mg/kg digoxin ip; 4, 5, 6, 7, 8, 10, and 12 hr later, groups of 7 amiodarone-pretreated and control animals were sacrificed, and plasma, heart, liver, muscle, brain, and kidney digoxin concentrations measured by radioimmunoassay. Data were analyzed by two-way ANOVA, with group comparisons using the Waller-Duncan multiple comparison procedure. Digoxin levels were significantly higher in the plasma, heart, muscle, and kidney of the amiodarone-pretreated rats at most points of measurement (P less than 0.05) whereas liver digoxin levels were elevated at 8, 10, and 12 hr. Kidney/plasma, heart/plasma, muscle/plasma, and especially liver/plasma ratios in the control groups significantly exceeded the values found in the amiodarone-pretreated group at most time points. Concentrations of digoxin in brain were not changed. This suggests that the volume of distribution is significantly altered in the amiodarone-pretreated group. Amiodarone increases plasma digoxin levels in rats as it does in humans, but the mechanism is unclear.
Weinhouse
E
E
Department of Pediatrics, Medical College of Wisconsin, Milwaukee.
Kaplanski
J
J
Zalzstein
E
E
Genchik
G
G
Colton
D
D
Nudel
D
D
D000465:Algorithms; D000638:Amiodarone / Q000493:pharmacokinetics*; D000818:Animals; D004077:Digoxin / Q000493:pharmacokinetics*; D004347:Drug Interactions; D008297:Male; D051381:Rats; D014018:Tissue Distribution
D004077:Digoxin; D000638:Amiodarone